Shinex-Uq Genetic Seeds Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
- Paid Up Capital ₹ 1.10 M
- Company Age 14 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 58.18%
- Profit Growth 2.24%
- Ebitda 1.61%
- Net Worth 16.78%
- Total Assets -33.66%
About Shinex-Uq Genetic Seeds
Shinex-Uq Genetic Seeds Private Limited (SGSPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 11 August 2010 and has a history of 14 years and five months. Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 1.10 M, as per Ministry of Corporate Affairs (MCA) records.
Swathi Basireddy and Sreenivasula Basireddy serve as directors at the Company.
Company Details
-
Location
Hyderabad, Telangana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U01403TG2010PTC069921
-
Company No.
069921
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
11 Aug 2010
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Shinex-Uq Genetic Seeds?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sreenivasula Basireddy
|
Managing Director | 11-Aug-2010 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Swathi Basireddy
|
Director | 07-Jul-2023 | Current |
Financial Performance of Shinex-Uq Genetic Seeds.
Shinex-Uq Genetic Seeds Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 58.18% increase. The company also saw a slight improvement in profitability, with a 2.24% increase in profit. The company's net worth Soared by an impressive increase of 16.78%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Shinex-Uq Genetic Seeds?
In 2023, Shinex-Uq Genetic Seeds had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Dakken Pioneer Seeds Private LimitedSwathi Basireddy is a mutual person
-
Subhasree Seeds Private Limited
Sreenivasula Basireddy is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Shinex-Uq Genetic Seeds?
Unlock and access historical data on people associated with Shinex-Uq Genetic Seeds, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Shinex-Uq Genetic Seeds, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shinex-Uq Genetic Seeds's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
